561 related articles for article (PubMed ID: 30126828)
1. Predictors of long-term survival after pancreaticoduodenectomy for peri-ampullary adenocarcinoma: A retrospective study of 5-year survivors.
El Nakeeb A; El Sorogy M; Ezzat H; Said R; El Dosoky M; Abd El Gawad M; Elsabagh AM; El Hanafy E
Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):443-449. PubMed ID: 30126828
[TBL] [Abstract][Full Text] [Related]
2. Longterm survival after pancreaticoduodenectomy for periampullary adenocarcinomas.
Chen SC; Shyr YM; Wang SE
HPB (Oxford); 2013 Dec; 15(12):951-7. PubMed ID: 23472708
[TBL] [Abstract][Full Text] [Related]
3. Pancreaticoduodenectomy for periampullary cancer: does the tumour entity influence perioperative morbidity and long-term outcome?
Wiltberger G; Krenzien F; Atanasov G; Hau HM; Schmelzle M; Bartels M; Benzing C
Acta Chir Belg; 2018 Dec; 118(6):341-347. PubMed ID: 30203717
[TBL] [Abstract][Full Text] [Related]
4. Palliative pancreaticoduodenectomy in pancreatic and periampullary adenocarcinomas.
Wang SE; Shyr YM; Su CH; Chen TH; Wu CW
Pancreas; 2012 Aug; 41(6):882-7. PubMed ID: 22286381
[TBL] [Abstract][Full Text] [Related]
5. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.
Yeo CJ; Cameron JL; Lillemoe KD; Sohn TA; Campbell KA; Sauter PK; Coleman J; Abrams RA; Hruban RH
Ann Surg; 2002 Sep; 236(3):355-66; discussion 366-8. PubMed ID: 12192322
[TBL] [Abstract][Full Text] [Related]
6. Effect of Pancreatic Fistula on Recurrence and Long-Term Prognosis of Periampullary Adenocarcinomas after Pancreaticoduodenectomy.
Serrano PE; Kim D; Kim PT; Greig PD; Moulton CA; Gallinger S; Wei AC; Cleary SP
Am Surg; 2016 Dec; 82(12):1187-1195. PubMed ID: 28234183
[TBL] [Abstract][Full Text] [Related]
7. Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma.
Westgaard A; Tafjord S; Farstad IN; Cvancarova M; Eide TJ; Mathisen O; Clausen OP; Gladhaug IP
BMC Cancer; 2008 Jun; 8():170. PubMed ID: 18547417
[TBL] [Abstract][Full Text] [Related]
8. Periampullary adenocarcinoma: analysis of 5-year survivors.
Yeo CJ; Sohn TA; Cameron JL; Hruban RH; Lillemoe KD; Pitt HA
Ann Surg; 1998 Jun; 227(6):821-31. PubMed ID: 9637545
[TBL] [Abstract][Full Text] [Related]
9. Survival advantage with para aortic lymphadenectomy in peri-ampullary cancer: A retrospective cohort study.
Hafeez Bhatti AB; Dar FS; Sahaab E; Khan NY; Zia H; Rana A; Salih M; Shah NH
Int J Surg; 2016 Jul; 31():58-62. PubMed ID: 27262530
[TBL] [Abstract][Full Text] [Related]
10. Pancreaticoduodenectomy: a 20-year experience in 516 patients.
Schmidt CM; Powell ES; Yiannoutsos CT; Howard TJ; Wiebke EA; Wiesenauer CA; Baumgardner JA; Cummings OW; Jacobson LE; Broadie TA; Canal DF; Goulet RJ; Curie EA; Cardenes H; Watkins JM; Loehrer PJ; Lillemoe KD; Madura JA
Arch Surg; 2004 Jul; 139(7):718-25; discussion 725-7. PubMed ID: 15249403
[TBL] [Abstract][Full Text] [Related]
11. Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor.
Westgaard A; Tafjord S; Farstad IN; Cvancarova M; Eide TJ; Mathisen O; Clausen OP; Gladhaug IP
BMC Cancer; 2008 Jan; 8():5. PubMed ID: 18194510
[TBL] [Abstract][Full Text] [Related]
12. Pylorus-preserving pancreatoduodenectomy. Is it an adequate cancer operation.
Tsao JI; Rossi RL; Lowell JA
Arch Surg; 1994 Apr; 129(4):405-12. PubMed ID: 7908796
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of prognosis-associated factors in pancreatic head and peri-ampullary cancer].
Roder JD; Siewert JR
Chirurg; 1992 May; 63(5):410-5. PubMed ID: 1376655
[TBL] [Abstract][Full Text] [Related]
14. The histopathologic type of the periampullary tumors. Is it important for survival?
Georgescu SO; Neacşu CN; Vintilă D; Popa P; Florea N; Mihailovici MS
Chirurgia (Bucur); 2009; 104(6):697-700. PubMed ID: 20187467
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors affecting survival after pancreaticoduodenectomy for pancreatic adenocarcinoma (single center experience).
El Nakeeb A; El Shobary M; El Dosoky M; Nabeh A; El Sorogy M; El Eneen AA; abu Zeid M; Elwahab MA
Hepatogastroenterology; 2014; 61(133):1426-38. PubMed ID: 25436321
[TBL] [Abstract][Full Text] [Related]
16. [Results of pancreaticoduodenectomy in the treatment of periampullary tumors].
Norero E; Viñuela E; Báez S; Martínez C; Reyes J; Kusanovic R; Sanhueza M; Aguayo G; Calvo A; Mege RM; Caracci M; Díaz A
Rev Med Chil; 2011 Aug; 139(8):1015-24. PubMed ID: 22215331
[TBL] [Abstract][Full Text] [Related]
17. Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-up.
Riall TS; Cameron JL; Lillemoe KD; Winter JM; Campbell KA; Hruban RH; Chang D; Yeo CJ
Surgery; 2006 Nov; 140(5):764-72. PubMed ID: 17084719
[TBL] [Abstract][Full Text] [Related]
18. Predictors of survival in periampullary cancers following pancreaticoduodenectomy.
Hatzaras I; George N; Muscarella P; Melvin WS; Ellison EC; Bloomston M
Ann Surg Oncol; 2010 Apr; 17(4):991-7. PubMed ID: 20108122
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological Stratification and Long-term Follow-up of Patients with Periampullary Carcinomas.
Schmuck RB; Brokat C; Andreou A; Felsenstein M; Klein F; Sinn B; Pratschke J; Bahra M
Anticancer Res; 2018 Sep; 38(9):5379-5386. PubMed ID: 30194192
[TBL] [Abstract][Full Text] [Related]
20. Survival after pancreaticoduodenectomy for periampullary adenocarcinoma: an update.
van Geenen RC; van Gulik TM; Offerhaus GJ; de Wit LT; Busch OR; Obertop H; Gouma DJ
Eur J Surg Oncol; 2001 Sep; 27(6):549-57. PubMed ID: 11520088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
